<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font16">for </span>
   <span class="font13">with </span>
   <span class="font13">that </span>
   <span class="font13">are </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">drug </span>
   <span class="font12">The </span>
   <span class="font12">coronavirus </span>
   <span class="font12">from </span>
   <span class="font11">COVID- </span>
   <span class="font11">clinical </span>
   <span class="font11">have </span>
   <span class="font11">viral </span>
   <span class="font11">protein </span>
   <span class="font11">treatment </span>
   <span class="font11">(), </span>
   <span class="font11">potential </span>
   <span class="font11">drugs </span>
   <span class="font11">this </span>
   <span class="font11">virus </span>
   <span class="font11">can </span>
   <span class="font11">severe </span>
   <span class="font11">has </span>
   <span class="font11">which </span>
   <span class="font11">also </span>
   <span class="font11">against </span>
   <span class="font11">inhibitors </span>
   <span class="font11">respiratory </span>
   <span class="font11">patients </span>
   <span class="font11">infection </span>
   <span class="font11">its </span>
   <span class="font11">new </span>
   <span class="font11">been </span>
   <span class="font11">proteins </span>
   <span class="font11">was </span>
   <span class="font10">patent </span>
   <span class="font10">protease </span>
   <span class="font10">RNA </span>
   <span class="font10">acute </span>
   <span class="font10">into </span>
   <span class="font10">syndrome </span>
   <span class="font10">host </span>
   <span class="font10">targets </span>
   <span class="font10">Med </span>
   <span class="font10">repurposing </span>
   <span class="font10">{background </span>
   <span class="font10">not </span>
   <span class="font10">remdesivir </span>
   <span class="font10">human </span>
   <span class="font10">studies </span>
   <span class="font10">such </span>
   <span class="font10">Nsp </span>
   <span class="font10">This </span>
   <span class="font10">cell </span>
   <span class="font10">therapeutic </span>
   <span class="font10">trials </span>
   <span class="font10">used </span>
   <span class="font10">Res </span>
   <span class="font10">could </span>
   <span class="font10">other </span>
   <span class="font10">these </span>
   <span class="font10">two </span>
   <span class="font10">structure </span>
   <span class="font10">vitro </span>
   <span class="font10">were </span>
   <span class="font10">compounds </span>
   <span class="font10">disease </span>
   <span class="font10">domain </span>
   <span class="font10">more </span>
   <span class="font10">use </span>
   <span class="font10">Fig. </span>
   <span class="font10">antiviral </span>
   <span class="font10">margin </span>
   <span class="font10">molecular </span>
   <span class="font10">novel </span>
   <span class="font10">synthesis </span>
   <span class="font10">(). </span>
   <span class="font10">authors </span>
   <span class="font10">main </span>
   <span class="font10">replication </span>
   <span class="font10">synthetic </span>
   <span class="font10">{border-style </span>
   <span class="font10">(Fig. </span>
   <span class="font10">activity </span>
   <span class="font10">may </span>
   <span class="font10">receptor </span>
   <span class="font10">some </span>
   <span class="font10">including </span>
   <span class="font10">px;} </span>
   <span class="font10">structural </span>
   <span class="font10">using </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">ACE </span>
   <span class="font10">SARS </span>
   <span class="font10">but </span>
   <span class="font10">first </span>
   <span class="font10">lopinavir </span>
   <span class="font10">their </span>
   <span class="font10">will </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">binding </span>
   <span class="font10">chloroquine </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">HCQ </span>
   <span class="font10">between </span>
   <span class="font10">discovery </span>
   <span class="font10">drugs, </span>
   <span class="font10">entry </span>
   <span class="font10">several </span>
   <span class="font10">target </span>
   <span class="font10">when </span>
   <span class="font10">Infect </span>
   <span class="font10">Mpro </span>
   <span class="font10">al. </span>
   <span class="font10">associated </span>
   <span class="font10">demonstrated </span>
   <span class="font10">gRNA </span>
   <span class="font10">pathway </span>
   <span class="font10">safety </span>
   <span class="font10">showed </span>
   <span class="font10">study </span>
   <span class="font10">through </span>
   <span class="font10">(SARS-CoV-) </span>
   <span class="font10">Struct </span>
   <span class="font10">[e.g., </span>
   <span class="font10">acid </span>
   <span class="font10">being </span>
   <span class="font10">cells </span>
   <span class="font10">computational </span>
   <span class="font10">days </span>
   <span class="font10">different </span>
   <span class="font10">important </span>
   <span class="font10">release </span>
   <span class="font10">shown </span>
   <span class="font10">spike </span>
   <span class="font10">three </span>
   <span class="font10">COVID-. </span>
   <span class="font10">These </span>
   <span class="font10">already </span>
   <span class="font10">baricitinib </span>
   <span class="font10">based </span>
   <span class="font10">described </span>
   <span class="font10">high </span>
   <span class="font10">immune </span>
   <span class="font10">inhibit </span>
   <span class="font10">interaction </span>
   <span class="font10">number </span>
   <span class="font10">performed </span>
   <span class="font10">polymerase </span>
   <span class="font10">possible </span>
   <span class="font10">proteases </span>
   <span class="font10">ritonavir </span>
   <span class="font10">role </span>
   <span class="font10">small </span>
   <span class="font10">steps </span>
   <span class="font10">structures </span>
   <span class="font10">there </span>
   <span class="font10">they </span>
   <span class="font10">trial </span>
   <span class="font10">Î¼M </span>
   <span class="font10">Biomol </span>
   <span class="font10">RdRp </span>
   <span class="font10">Sci </span>
   <span class="font10">data </span>
   <span class="font10">found </span>
   <span class="font10">fusion </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">key </span>
   <span class="font10">membrane </span>
   <span class="font10">most </span>
   <span class="font10">natural </span>
   <span class="font10">one </span>
   <span class="font10">promising </span>
   <span class="font10">than </span>
   <span class="font10">type </span>
   <span class="font10">well </span>
   <span class="font10">()] </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">(e.g., </span>
   <span class="font10">Chem </span>
   <span class="font10">Dyn./.. </span>
   <span class="font10">Ritonavir </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">Virol </span>
   <span class="font10">approved </span>
   <span class="font10">compared </span>
   <span class="font10">development </span>
   <span class="font10">efficacy </span>
   <span class="font10">essential </span>
   <span class="font10">include </span>
   <span class="font10">intermediate </span>
   <span class="font10">mechanism </span>
   <span class="font10">out </span>
   <span class="font10">production </span>
   <span class="font10">related </span>
   <span class="font10">reported </span>
   <span class="font10">results </span>
   <span class="font10">time </span>
   <span class="font10">under </span>
   <span class="font10">via </span>
   <span class="font10">while </span>
   <span class="font10">Discov </span>
   <span class="font10">Engl </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Other </span>
   <span class="font10">Rev </span>
   <span class="font10">activities </span>
   <span class="font10">analysis </span>
   <span class="font10">animal </span>
   <span class="font10">available </span>
   <span class="font10">both </span>
   <span class="font10">cellular </span>
   <span class="font10">chemical </span>
   <span class="font10">cleavage </span>
   <span class="font10">collab: </span>
   <span class="font10">company </span>
   <span class="font10">docking </span>
   <span class="font10">envelope </span>
   <span class="font10">enzyme </span>
   <span class="font10">final </span>
   <span class="font10">form </span>
   <span class="font10">g., </span>
   <span class="font10">large </span>
   <span class="font10">many </span>
   <span class="font10">molecules </span>
   <span class="font10">predicted </span>
   <span class="font10">responsible </span>
   <span class="font10">site </span>
   <span class="font10">still </span>
   <span class="font10">strategies </span>
   <span class="font10">system </span>
   <span class="font10">Acids </span>
   <span class="font10">Baricitinib </span>
   <span class="font10">Biol </span>
   <span class="font10">Drug </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">However, </span>
   <span class="font10">NCT </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">SARS-CoVs </span>
   <span class="font10">Therefore, </span>
   <span class="font10">They </span>
   <span class="font10">after </span>
   <span class="font10">candidates </span>
   <span class="font10">catalytic </span>
   <span class="font10">daily </span>
   <span class="font10">day </span>
   <span class="font10">drug-target </span>
   <span class="font10">early </span>
   <span class="font10">effect </span>
   <span class="font10">function </span>
   <span class="font10">hydrolysis </span>
   <span class="font10">infected </span>
   <span class="font10">inhibition </span>
   <span class="font10">ion </span>
   <span class="font10">making </span>
   <span class="font10">methods </span>
   <span class="font10">model </span>
   <span class="font10">need </span>
   <span class="font10">only </span>
   <span class="font10">over </span>
   <span class="font10">px; </span>
   <span class="font10">randomised </span>
   <span class="font10">reaction </span>
   <span class="font10">represented </span>
   <span class="font10">research </span>
   <span class="font10">strategy </span>
   <span class="font10">them </span>
   <span class="font10">twice </span>
   <span class="font10">vivo </span>
   <span class="font10">{font-family </span>
   <span class="font10">(NCT) </span>
   <span class="font10">(e. </span>
   <span class="font10">Agents </span>
   <span class="font10">Gilead </span>
   <span class="font10">IL- </span>
   <span class="font10">Its </span>
   <span class="font10">MERS </span>
   <span class="font10">PLpro </span>
   <span class="font10">Phase </span>
   <span class="font10">about </span>
   <span class="font10">all </span>
   <span class="font10">any </span>
   <span class="font10">approach </span>
   <span class="font10">approaches </span>
   <span class="font10">around </span>
   <span class="font10">block </span>
   <span class="font10">chiral </span>
   <span class="font10">clinically </span>
   <span class="font10">coloured </span>
   <span class="font10">combination </span>
   <span class="font10">cost </span>
   <span class="font10">discussed </span>
   <span class="font10">domains </span>
   <span class="font10">domains: </span>
   <span class="font10">effects </span>
   <span class="font10">evidence </span>
   <span class="font10">explored </span>
   <span class="font10">font-size </span>
   <span class="font10">four </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">helicase </span>
   <span class="font10">identify </span>
   <span class="font10">infection, </span>
   <span class="font10">information </span>
   <span class="font10">inhibits </span>
   <span class="font10">learning </span>
   <span class="font10">like </span>
   <span class="font10">lower </span>
   <span class="font10">molecule </span>
   <span class="font10">nsp </span>
   <span class="font10">observed </span>
   <span class="font10">overall </span>
   <span class="font10">papain-like </span>
   <span class="font10">pathways </span>
   <span class="font10">patient </span>
   <span class="font10">plasma </span>
   <span class="font10">plus </span>
   <span class="font10">polyproteins </span>
   <span class="font10">produce </span>
   <span class="font10">proposed </span>
   <span class="font10">proteins. </span>
   <span class="font10">repurposed </span>
   <span class="font10">repurposing. </span>
   <span class="font10">same </span>
   <span class="font10">should </span>
   <span class="font10">since </span>
   <span class="font10">surface </span>
   <span class="font10">translated </span>
   <span class="font10">treated </span>
   <span class="font10">treatment. </span>
   <span class="font10">treatments </span>
   <span class="font10">until </span>
   <span class="font10">very </span>
   <span class="font10">where </span>
   <span class="font10">()/lopinavir </span>
   <span class="font10">(Maestro, </span>
   <span class="font10">(PDB </span>
   <span class="font10">Abbott </span>
   <span class="font10">Both </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Clin </span>
   <span class="font10">CoVs </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">East </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">III </span>
   <span class="font10">LLC, </span>
   <span class="font10">Maestro, </span>
   <span class="font10">NY, </span>
   <span class="font10">New </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">SchrÃ¶dinger, </span>
   <span class="font10">Some </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">Ther </span>
   <span class="font10">York, </span>
   <span class="font10">accessory </span>
   <span class="font10">allowing </span>
   <span class="font10">amino </span>
   <span class="font10">angiotensin </span>
   <span class="font10">aspects </span>
   <span class="font10">assembly </span>
   <span class="font10">because </span>
   <span class="font10">cathepsin </span>
   <span class="font10">cells. </span>
   <span class="font10">chloride </span>
   <span class="font10">confirmation </span>
   <span class="font10">contains </span>
   <span class="font10">control </span>
   <span class="font10">created </span>
   <span class="font10">cycle </span>
   <span class="font10">cytokine </span>
   <span class="font10">deep </span>
   <span class="font10">developed </span>
   <span class="font10">diabetes </span>
   <span class="font10">double-blind, </span>
   <span class="font10">double; </span>
   <span class="font10">drug, </span>
   <span class="font10">during </span>
   <span class="font10">even </span>
   <span class="font10">expression </span>
   <span class="font10">functional </span>
   <span class="font10">group </span>
   <span class="font10">higher </span>
   <span class="font10">identified </span>
   <span class="font10">importance </span>
   <span class="font10">increase </span>
   <span class="font10">inflammatory </span>
   <span class="font10">interactions </span>
   <span class="font10">knowledge </span>
   <span class="font10">less </span>
   <span class="font10">major </span>
   <span class="font10">models </span>
   <span class="font10">once </span>
   <span class="font10">ongoing </span>
   <span class="font10">pandemic </span>
   <span class="font10">pneumonia </span>
   <span class="font10">potent </span>
   <span class="font10">presented </span>
   <span class="font10">protection </span>
   <span class="font10">recent </span>
   <span class="font10">respectively. </span>
   <span class="font10">response </span>
   <span class="font10">risk </span>
   <span class="font10">targeting </span>
   <span class="font10">toxic </span>
   <span class="font10">toxicity </span>
   <span class="font10">transmembrane </span>
   <span class="font10">treat </span>
   <span class="font10">viruses </span>
   <span class="font10">yield </span>
   <span class="font10">(family: </span>
   <span class="font10">-nCoV </span>
   <span class="font10">Acad </span>
   <span class="font10">After </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">COVID-J </span>
   <span class="font10">China, </span>
   <span class="font10">Clinical </span>
   <span class="font10">Covid-N </span>
   <span class="font10">DPP </span>
   <span class="font10">Dis </span>
   <span class="font10">For </span>
   <span class="font10">Lopinavir </span>
   <span class="font10">Microbiol </span>
   <span class="font10">N-terminal </span>
   <span class="font10">Pathoge </span>
   <span class="font10">Pharmacol </span>
   <span class="font10">Recently, </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">There </span>
   <span class="font10">VdW </span>
   <span class="font10">addition, </span>
   <span class="font10">affording </span>
   <span class="font10">agent </span>
   <span class="font10">among </span>
   <span class="font10">base </span>
   <span class="font10">beneficial </span>
   <span class="font10">best </span>
   <span class="font10">biological </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">called </span>
   <span class="font10">catalyses </span>
   <span class="font10">caused </span>
   <span class="font10">characteristics </span>
   <span class="font10">companies </span>
   <span class="font10">complex </span>
   <span class="font10">concerning </span>
   <span class="font10">consider </span>
   <span class="font10">countries. </span>
   <span class="font10">cytoplasm </span>
   <span class="font10">database </span>
   <span class="font10">disease, </span>
   <span class="font10">diseases </span>
   <span class="font10">domain. </span>
   <span class="font10">dynamics </span>
   <span class="font10">each </span>
   <span class="font10">effectiveness </span>
   <span class="font10">efforts </span>
   <span class="font10">encode </span>
   <span class="font10">endosomal </span>
   <span class="font10">endosomes </span>
   <span class="font10">epidemic </span>
   <span class="font10">epithelial </span>
   <span class="font10">expensive </span>
   <span class="font10">expressed </span>
   <span class="font10">family </span>
   <span class="font10">find </span>
   <span class="font10">five </span>
   <span class="font10">good </span>
   <span class="font10">graph </span>
   <span class="font10">had </span>
   <span class="font10">health </span>
   <span class="font10">infections </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">initial </span>
   <span class="font10">insights </span>
   <span class="font10">instance, </span>
   <span class="font10">investigation </span>
   <span class="font10">kinase </span>
   <span class="font10">known </span>
   <span class="font10">located </span>
   <span class="font10">low </span>
   <span class="font10">lung </span>
   <span class="font10">manufacturing </span>
   <span class="font10">market </span>
   <span class="font10">mercaptopurine </span>
   <span class="font10">method </span>
   <span class="font10">nucleocapsid </span>
   <span class="font10">nucleotide </span>
   <span class="font10">one-pot </span>
   <span class="font10">open </span>
   <span class="font10">options </span>
   <span class="font10">palm </span>
   <span class="font10">patents </span>
   <span class="font10">pathology </span>
   <span class="font10">patients, </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">point </span>
   <span class="font10">potentially </span>
   <span class="font10">prevention </span>
   <span class="font10">process </span>
   <span class="font10">published </span>
   <span class="font10">randomised, </span>
   <span class="font10">receptors </span>
   <span class="font10">represent </span>
   <span class="font10">review </span>
   <span class="font10">selection </span>
   <span class="font10">sequence </span>
   <span class="font10">serine </span>
   <span class="font10">showing </span>
   <span class="font10">signaling </span>
   <span class="font10">similar </span>
   <span class="font10">simulation </span>
   <span class="font10">size </span>
   <span class="font10">solid; </span>
   <span class="font10">starting </span>
   <span class="font10">step </span>
   <span class="font10">structure, </span>
   <span class="font10">subunit </span>
   <span class="font10">suggested </span>
   <span class="font10">suitable </span>
   <span class="font10">those </span>
   <span class="font10">transmission </span>
   <span class="font10">validation </span>
   <span class="font10">virion </span>
   <span class="font10">within </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(A) </span>
   <span class="font10">(Available </span>
   <span class="font10">(B) </span>
   <span class="font10">(EC </span>
   <span class="font10">(Nsp) </span>
   <span class="font10">(pink) </span>
   <span class="font10">Additionally, </span>
   <span class="font10">China </span>
   <span class="font10">Co. </span>
   <span class="font10">Commun </span>
   <span class="font10">Finally, </span>
   <span class="font10">HIV </span>
   <span class="font10">His </span>
   <span class="font10">Incyte </span>
   <span class="font10">Lilly </span>
   <span class="font10">Microbes </span>
   <span class="font10">Nsps </span>
   <span class="font10">Oswaldo </span>
   <span class="font10">PDB </span>
   <span class="font10">Pharm </span>
   <span class="font10">ResDDD </span>
   <span class="font10">Syndrome </span>
   <span class="font10">Vero </span>
   <span class="font10">Wuhan </span>
   <span class="font10">aa) </span>
   <span class="font10">act </span>
   <span class="font10">activation </span>
   <span class="font10">active </span>
   <span class="font10">acts </span>
   <span class="font10">administration </span>
   <span class="font10">adults </span>
   <span class="font10">agents </span>
   <span class="font10">allows </span>
   <span class="font10">alveolar </span>
   <span class="font10">and/or </span>
   <span class="font10">another </span>
   <span class="font10">antiparasitic </span>
   <span class="font10">assays </span>
   <span class="font10">basis </span>
   <span class="font10">become </span>
   <span class="font10">beta </span>
   <span class="font10">bind </span>
   <span class="font10">blockers </span>
   <span class="font10">bold </span>
   <span class="font10">bound </span>
   <span class="font10">candidate </span>
   <span class="font10">care </span>
   <span class="font10">cases </span>
   <span class="font10">cells, </span>
   <span class="font10">centres, </span>
   <span class="font10">channel </span>
   <span class="font10">chronic </span>
   <span class="font10">clan: </span>
   <span class="font10">cleaved </span>
   <span class="font10">cofactor </span>
   <span class="font10">common </span>
   <span class="font10">comparing </span>
   <span class="font10">composed </span>
   <span class="font10">compound </span>
   <span class="font10">connected </span>
   <span class="font10">consecutive </span>
   <span class="font10">copy </span>
   <span class="font10">courier; </span>
   <span class="font10">creating </span>
   <span class="font10">databases </span>
   <span class="font10">day, </span>
   <span class="font10">deal </span>
   <span class="font10">design </span>
   <span class="font10">developing </span>
   <span class="font10">divided </span>
   <span class="font10">dosage </span>
   <span class="font10">edges </span>
   <span class="font10">effectively </span>
   <span class="font10">em; </span>
   <span class="font10">enhance </span>
   <span class="font10">eriodictyol </span>
   <span class="font10">experimental </span>
   <span class="font10">explore </span>
   <span class="font10">factors </span>
   <span class="font10">followed </span>
   <span class="font10">following </span>
   <span class="font10">formation </span>
   <span class="font10">from: </span>
   <span class="font10">further </span>
   <span class="font10">gene </span>
   <span class="font10">generic </span>
   <span class="font10">genomic </span>
   <span class="font10">giving </span>
   <span class="font10">gray </span>
   <span class="font10">humans </span>
   <span class="font10">hypericin </span>
   <span class="font10">improved </span>
   <span class="font10">improvement </span>
   <span class="font10">increasing </span>
   <span class="font10">index </span>
   <span class="font10">indicated </span>
   <span class="font10">industrial </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibitory </span>
   <span class="font10">interact </span>
   <span class="font10">interesting </span>
   <span class="font10">interferon </span>
   <span class="font10">investigated </span>
   <span class="font10">involved </span>
   <span class="font10">involving </span>
   <span class="font10">late </span>
   <span class="font10">lungs </span>
   <span class="font10">measures </span>
   <span class="font10">medical </span>
   <span class="font10">membranes </span>
   <span class="font10">modifications </span>
   <span class="font10">needs </span>
   <span class="font10">network </span>
   <span class="font10">networks </span>
   <span class="font10">nodes </span>
   <span class="font10">non-randomised </span>
   <span class="font10">nonstructural </span>
   <span class="font10">numbers </span>
   <span class="font10">obtained </span>
   <span class="font10">optimised </span>
   <span class="font10">pandemic. </span>
   <span class="font10">pathway, </span>
   <span class="font10">peptide </span>
   <span class="font10">position </span>
   <span class="font10">ppa/ppab </span>
   <span class="font10">preparation </span>
   <span class="font10">present </span>
   <span class="font10">protease, </span>
   <span class="font10">protect </span>
   <span class="font10">proteolytic </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently </span>
   <span class="font10">replication, </span>
   <span class="font10">repositioning </span>
   <span class="font10">representation </span>
   <span class="font10">repurposable </span>
   <span class="font10">require </span>
   <span class="font10">requires </span>
   <span class="font10">screening </span>
   <span class="font10">sequences </span>
   <span class="font10">seven </span>
   <span class="font10">side </span>
   <span class="font10">significant </span>
   <span class="font10">similarity </span>
   <span class="font10">sirolimus </span>
   <span class="font10">sites </span>
   <span class="font10">social </span>
   <span class="font10">standard </span>
   <span class="font10">studies, </span>
   <span class="font10">subdomain </span>
   <span class="font10">subgenomic </span>
   <span class="font10">symptoms </span>
   <span class="font10">term </span>
   <span class="font10">tertiary </span>
   <span class="font10">tested </span>
   <span class="font10">therapy </span>
   <span class="font10">thumb </span>
   <span class="font10">translation, </span>
   <span class="font10">triphosphate </span>
   <span class="font10">useful </span>
   <span class="font10">view </span>
   <span class="font10">wastewater </span>
   <span class="font10">without </span>
   <span class="font10">Ã…) </span>
   <span class="font10">Ã…, </span>
   <span class="font10">Î¼M. </span>
  </p>
 </body>
</html>
